Commentary

Evaluating the impact of FDA’s pregnancy and lactation labeling rule


 

Dr. Chambers is a professor of pediatrics and director of clinical research at Rady Children’s Hospital, and associate director of the Clinical and Translational Research Institute at the University of California, San Diego. She is director of MotherToBaby California, a past president of the Organization of Teratology Information Specialists, and past president of the Teratology Society. She has no relevant financial disclosures. To comment, e-mail her at obnews@frontlinemedcom.com.

Pages

Recommended Reading

Eating fried food before pregnancy may increase risk of gestational diabetes
MDedge Internal Medicine
Maternal weight before pregnancy linked to children’s cognition
MDedge Internal Medicine
Retinopathy screening during gestational diabetes may be lacking
MDedge Internal Medicine
Drugs, Pregnancy, and Lactation: Herbs
MDedge Internal Medicine
Timing of lifestyle interventions for obesity
MDedge Internal Medicine
Children born to mothers with RA more likely to be born early
MDedge Internal Medicine
Kidney donors at greater risk of preeclampsia, gestational hypertension
MDedge Internal Medicine
Topiramate
MDedge Internal Medicine
FDA issues new pregnancy/lactation drug label standards
MDedge Internal Medicine
Consider biopsy for active lupus nephritis in pregnancy
MDedge Internal Medicine

Related Articles